BiotechTube

Hydrocortisone acetate and lidocaine hydrochloride + Placebo control + Hydrocortisone acetate + Lidocaine hydrochloride

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hemorrhoids

Conditions

Hemorrhoids

Trial Timeline

May 1, 2015 → Oct 1, 2015

NCT ID
NCT02689856

About Hydrocortisone acetate and lidocaine hydrochloride + Placebo control + Hydrocortisone acetate + Lidocaine hydrochloride

Hydrocortisone acetate and lidocaine hydrochloride + Placebo control + Hydrocortisone acetate + Lidocaine hydrochloride is a phase 2 stage product being developed by Citius Pharmaceuticals for Hemorrhoids. The current trial status is completed. This product is registered under clinical trial identifier NCT02689856. Target conditions include Hemorrhoids.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02689856Phase 2Completed

Competing Products

2 competing products in Hemorrhoids

See all competitors
ProductCompanyStageHype Score
Relief Pro cream + Relief Pro rectal suppositoriesBayerPre-clinical
20
Monad 1 + Monad 2 + Monad 3 + Combination - CITI-002 (low dose) + Combination - CITI-002 (high dose)Citius PharmaceuticalsPhase 2
44

Other Products from Citius Pharmaceuticals

Monad 1 + Monad 2 + Monad 3 + Combination - CITI-002 (low dose) + Combination - CITI-002 (high dose)Phase 2
44